Diabetes Education meetings & conferences

5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948    
Fax: +41 (0)22 580 2953

General Enquiries

Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com  
Fax: +41 (0)22 580 2953

4th Arab Diabetes Forum

4-6 September 2013 Cairo, Egypt

Target Audience

Physicians, researchers, nurses, nurse practitioners, dietitians, podiatrists, pharmacists, psychologists, Endocrinologists, Diabetes Educators, People interested in diabetes, People with diabetes, Diabetes health professionals, and other health care professionals.

Theme Areas

1- KOL Meetings for Arab Diabetes Alliance.

2- Diabetes in the Arab World:

•Prevalence / Registry
•Cost / Complications
•Cultural Aspects
•Arabic Guidelines

3- Debates and controversies:

•Safety and Efficacy
•Hypos versus hyperglycemia
•Guidelines: which?

4- Workshops and Education Programs.

5- Updates in

•Understanding pathogenesis
•New therapies
•Diabetic dyslipidemia

World Diabetes Congress

The next World Diabetes Congress will be held at the Melbourne Convention and Exhibition Centre, Melbourne, Australia from 2 to 6 December 2013.

The International Diabetes Federation is the global voice for people with diabetes and those at risk. Twenty years after the World Diabetes Congress in Japan, the Western Pacific Region is again in the global health spotlight and is why we have chosen Melbourne to host the World Diabetes Congress in 2013.

Today, more than a third of all people with diabetes are found in the Western Pacific Region. It is also the region that has the highest number of undiagnosed cases and the highest number of deaths attributable to diabetes.